CLINICAL_TRIALS
trial_result
· 2021-06-23
Clinical Trial Update: Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease [Phase 2]
Summary
Phase 2 trial update on discontinuation or continuation of immunosuppressive therapy in participants with chronic graft-versus-host disease (GVHD); results post…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fred Hutchinson Cancer Center | Conditions: Chronic Graft Versus Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-06-23